azathioprine has been researched along with Dysembryoma in 2 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Karam, G | 1 |
Vasse, N | 1 |
Cathelineau, X | 1 |
Buzelin, F | 1 |
Buzelin, JM | 1 |
Leb, DE | 1 |
Howell, RS | 1 |
2 other studies available for azathioprine and Dysembryoma
Article | Year |
---|---|
[Testicular tumor in renal and pancreatic transplantation].
Topics: Azathioprine; Cyclosporine; Follow-Up Studies; Graft Rejection; Humans; Immunosuppression Therapy; I | 1998 |
Carcinoma of the testis in a renal transplant recipient.
Topics: Adult; Azathioprine; Cell Transformation, Neoplastic; Humans; Immunosuppressive Agents; Kidney Trans | 1971 |